Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Overview of DNA Repair02:25

Overview of DNA Repair

7.8K
7.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete genome sequencing of the fowlpox virus vaccine strain from the Livestock Research Institute, Bangladesh.

Microbiology resource announcements·2026
Same author

MutAIverse: an AI-powered, mechanism-backed platform for discovering novel DNA adducts and their precursor genotoxins.

Journal of cheminformatics·2026
Same author

Expert Consensus on the Management of Hyperpigmentation Disorders in India: A Modified Delphi Study by the Pigmentary Disorders Society.

International journal of dermatology·2026
Same author

Direct MALDI-TOF MS identification from positive blood culture bottles: a time-saving approach to reduce diagnostic delays.

Journal of infection in developing countries·2026
Same author

First complete genome of a fowlpox virus isolated in Bangladesh reveals Asian lineage and clade A1.

Microbiology spectrum·2026
Same author

Skin Allergy Research Society and Society for Eczema Studies Joint Task Force Guidelines of Care for Management of Atopic Dermatitis for Adults, Children, and Special Populations in India: An Evidence-Based Review and an Expert Consensus.

Indian journal of dermatology·2026

Related Experiment Video

Updated: Sep 13, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.5K

HPV Vaccines - An Overview.

Aparajita Ghosh1, Sambit Chatterjee1, Ananya Dawn1

  • 1From the Department of Dermatology, Venereology and Leprosy, KPC Medical College and Hospital, West Bengal, India.

Indian Journal of Dermatology
|July 31, 2025
PubMed
Summary

Human papilloma virus (HPV) vaccines protect against HPV infections and related cancers. Available vaccines are safe and effective for preventing cervical intra-epithelial neoplasia, with ongoing research into therapeutic uses.

Keywords:
Human papilloma virusnonavalentquadrivalent

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.5K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.3K

Area of Science:

  • Oncology
  • Virology
  • Vaccinology

Background:

  • Human papilloma viruses (HPVs) are oncogenic, causing significant global cancer burden.
  • Prophylactic HPV vaccines (bivalent, quadrivalent, nonavalent) have been developed since 2006.
  • Current vaccines target high-risk HPV types (16, 18) and low-risk types (6, 11).

Purpose of the Study:

  • To review currently available prophylactic HPV vaccines.
  • To discuss their indications, safety, and epidemiological impact.
  • To explore off-label therapeutic uses and potential future vaccine candidates.

Main Methods:

  • Review of existing literature on HPV vaccines.
  • Analysis of clinical trial data regarding vaccine efficacy and safety.
  • Examination of epidemiological data on HPV-related cancer prevention.

Main Results:

  • HPV vaccines are safe and highly effective in preventing cervical intra-epithelial neoplasia grades 2 and 3.
  • Bivalent vaccines target HPV 16/18 (70% of cervical cancers); quadrivalent/nonavalent vaccines include protection against HPV 6/11.
  • Therapeutic efficacy remains under investigation with conflicting reports.

Conclusions:

  • Current HPV vaccines are approved for prophylactic use and demonstrate excellent safety and efficacy.
  • Further research is needed to establish the role of HPV vaccines in preventing other cancers and for therapeutic applications.